Dr. Klisovic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UH Cleveland Medical Center
11100 Euclid Ave Department of Medicine-Hematology and Oncology
Cleveland, OH 44106Phone+1 216-844-3951Fax+1 216-844-5234- Is this information wrong?
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2001 - 2004
- University of North Carolina HospitalsResidency, Internal Medicine, 1997 - 2000
- Ohio State University College of MedicineClass of 1997
- Case Western Reserve UniversityBS, Biomedical Engineering, 1989 - 1993
Certifications & Licensure
- OH State Medical License 2001 - 2025
- GA State Medical License 2017 - 2022
- NC State Medical License 1998 - 2001
- American Board of Internal Medicine Medical Oncology
- EpicPhysician Builder
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML) Start of enrollment: 2007 Aug 01
- Correlative Biomarker Study in Patients With Myeloproliferative Disorders Start of enrollment: 2007 Apr 01
- Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia Start of enrollment: 2010 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPhase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia.Bhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, Sumithira Vasu, Gregory K Behbehani, Karilyn Larkin, James S Blachly, Mohamed A Badawi, Kasey L Hill, Kyle R Dzwigalski,...> ;Leukemia & Lymphoma. 2023 Dec 1
- 29 citationsSWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphobla...Anjali S Advani, Anna Moseley, Kristen M O'Dwyer, Brent L Wood, Min Fang, Matthew J Wieduwilt, Ibrahim Aldoss, Jae H Park, Rebecca B Klisovic, Maria R Baer, Wendy Stoc...> ;Journal of Clinical Oncology. 2022 May 10
- 4 citationsA phase 2a, single-arm, open-label study of tafasitamab, a humanized, Fc-modified, anti-CD19 antibody, in patients with relapsed/refractory B-precursor cell acute lymp...Rebecca B. Klisovic, Wing Hang Leung, Wolfram Brugger, Maren Dirnberger-Hertweck, Mark Winderlich, Sumeet Ambarkhane, Elias Jabbour> ;Cancer. 2021 Nov 15
- Join now to see all
Authored Content
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 MutationJune 2017
Press Mentions
- OncLive® Presents State of the Science Summit™ on Hematologic MalignanciesOctober 31st, 2019
- Turning Points: Together in Sickness, Married in HealthAugust 1st, 2016
- Bone-Marrow Donor Travels from Israel for Wedding of Transplant RecipientApril 29th, 2016
- Join now to see all
Grant Support
- Gti-2040: An Anti-Sense Strategy To Reduce Ribonucleotide Reductase In AMLNational Cancer Institute2009–2010
Professional Memberships
- Member
- Member
- ASBMTMember
- Member
Hospital Affiliations
- University Hospitals Cleveland Medical CenterCleveland, Ohio
- Emory University HospitalAtlanta, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: